Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Grow a Spine—Researchers Explain Brain Boost in Tauopathy Mice
9 December 2011. It’s become conventional wisdom in Alzheimerology that tau pathology tends to track with mental decline in people with Alzheimer’s dementia, yet several years ago scientists found, to their surprise, that certain tauopathy mice actually have sharper cognition than wild-type mice early in life, before cognition tanks later on. Now, a study in the December 7 Journal of Neuroscience suggests that clues to this conundrum lie in dendritic spines. Fred Van Leuven and colleagues at the University of Leuven in Belgium report that young, brainy tau P301L mice have faster-maturing, longer spines than older siblings whose cognition is slipping. The older tau mice have stubby spines and sprout more of them, relative to control mice with normal tau. In addition, biochemical and immunohistochemical experiments help bolster the notion that tau’s physiological actions differ widely from its pathological doings.

Transgenic mice expressing P301L mutant human tau develop neurofibrillary tangles and motor problems, and most die before 10 months of age (Terwel et al., 2005). Curiously, though, in their youth (eight to 10 weeks of age), these same mice have increased long-term potentiation in the dentate gyrus and outperform wild-type littermates in a test of object recognition memory (ARF related news story on Boekhoorn et al., 2006). “It was a surprise that mutant tau could actually be beneficial,” Van Leuven said.

To probe the underlying mechanism, his team looked at what tau was doing to dendritic spines. First author Anna Kremer and colleagues crossed tau P301L mice—as well as the tau 4R strain expressing wild-type human tau at similar levels—with yellow fluorescent protein (YFP) mice to visualize axons, dendrites, and dendritic spines in vivo in bigenic progeny. Using confocal microscopy, the researchers imaged four brain areas affected by tauopathy and AD—the stratum, radiatum, and stratum oriens in the hippocampus, and cortical layer III above the striatum and above the hippocampus. They did so in young (one- to two-month-old) and adult (seven- to eight-month-old) mice. They measured the spine density, spine length, and spine maturation index, the last being the ratio of mushroom spines—which have mature, functional synapses—to all other spine types.

Analyzing nearly 58,000 spines in total for 20 mice, Kremer and colleagues found that, relative to YFP-only controls, young tau P301L mice sprouted normal numbers of spines, but an unusually high proportion of them were mature. In adult P301L transgenics, maturation index and spine length returned back to control levels, yet spine density remained high. The team saw similar effects in adult tau 4R mice, suggesting that wild-type and mutant tau may affect spine formation and morphology in comparable ways.

The researchers analyzed tau P301L and wild-type mouse brain for biochemical markers that could explain how tau proteins drive spine changes. They found both human P301L tau and endogenous mouse tau in synaptosomes, as judged by Western blot. However, immunohistochemistry using a variety of methods failed to detect appreciable amounts of mouse tau in dendritic spines; only human transgenic tau was there. This suggests that “tau’s actions in physiological conditions are quite different from its actions in pathological conditions,” Van Leuven said.

Jochen Herms of Ludwig-Maximilians University in Munich, Germany, pointed out, as did the authors, that it is possible that spine changes could result not only from dendritic pathology, but also from axonal signals. Axonal pathology has been shown to cause secondary spine loss in other tau-overexpressing transgenic mice, Herms noted in an e-mail to ARF. Tau is predominantly an axonal protein (see Hoover et al., 2010; Zempel et al., 2010), only moving into soma or dendrites when abnormally phosphorylated (see ARF related news story).

The mechanism behind the accelerated spine maturation in young tau P301L mice remains unknown. Dezhi Liao of the University of Minnesota, Minneapolis, speculated the enhancement could be due to compensation effects. Liao and others have shown that spine density and maturation goes up when AMPA receptor activity is blocked in cultured neurons, for instance (Liao et al., 1999; O’Brien et al., 1998).—Esther Landhuis.

Reference:
Kremer A, Maurin H, Demedts D, Devijver H, Borghgraef P, Van Leuven F. Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice. J Neurosci. 7 Dec 2011;31(49):18036-47. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad